4 March 2021
ECO Animal Health Group plc ("the Company")
(AIM: EAH)
Result of Annual General Meeting and General Meeting
ECO Animal Health Group plc announces that at both its Annual General Meeting and General Meeting held earlier today ("AGM" and "GM" respectively), all resolutions proposed to the meetings were duly passed on a poll.
At the AGM the total votes cast on each resolution were as follows:
Resolution |
For |
% |
Against |
% |
Withheld |
1 |
39,817,344 |
97.68 |
946,305 |
2.32 |
1,452 |
2 |
40,763,180 |
99.99 |
469 |
0.01 |
1,452 |
3 |
40,751,532 |
99.97 |
12,117 |
0.03 |
1,452 |
4 |
40,761,973 |
99.99 |
1,676 |
0.01 |
1,452 |
5 |
40,760,507 |
99.99 |
4,141 |
0.01 |
453 |
6 |
40,316,884 |
98.90 |
447,764 |
1.10 |
453 |
7 |
40,759,099 |
99.99 |
5,549 |
0.01 |
453 |
At the GM the total votes cast on each resolution were as follows:
Resolution |
For |
% |
Against |
% |
Withheld |
1 |
39,491,382 |
96.74 |
886,334 |
2.17 |
445,053 |
2 |
36,701,055 |
89.90 |
3,676,661 |
9.01 |
445,053 |
Contacts:
ECO Animal Health Group plc Marc Loomes (CEO) Christopher Wilks (CFO)
|
|
IFC Advisory Graham Herring Zach Cohen
|
020 3934 6630
|
N+1 Singer (Nominated Adviser & Joint Broker) Mark Taylor Iqra Amin
|
020 7496 3000 |
Peel Hunt LLP (Joint Broker) James Steel Dr Christopher Golden |
020 7418 8900 |
About ECO Animal Health
ECO Animal Health Group plc ("ECO" or "the GROUP") researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development ("R&D") for new products, particularly vaccines, and seeking to in-license new product